A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care

Aim To examine the predictors of direct costs of pediatric type 1 diabetes (T1D) in a hospital‐based outpatient clinic in Greece. Methods The outpatient records of 89 children and adolescents (mean age: 12.05 ± 5.15 y) with T1D followed in the Second Department of Pediatrics, University of Athens Medical School, were analyzed. Results The mean ± SD diabetes duration was 4.9 ± 3.88 y (range: 0.25‐17) and glycated hemoglobin (HbA1c) was 8.2 ± 1.09% (66 ± 11.9 mmol/mol). A total of 80% of patients were on multiple daily injections regimen, 10% on pump therapy, and 10% on conventional regimen. Total direct costs per patient‐year (ppy) were estimated at €2.712 [95% confidence interval (CI): 2.468‐2.956]. Supply costs accounted for 73.7% of total costs and were the highest for pump therapy (P